NCT05984810View on ClinicalTrials.gov

NIR-Fluorescence Guided Surgical Resection of Neoadjuvant Treated Localized Pancreatic Cancer Using SGM-101

PHASE2RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 18, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Pancreas Adenocarcinoma
Interventions
PROCEDURE

Fluorescence-guided surgery using CEA-targeted fluorophore SGM-101

Fluorescence-guided surgery using CEA-targeted fluorophore SGM-101

Trial Locations (1)

2300RC

RECRUITING

Leiden University Medical Center, Leiden

Sponsors

Collaborators (1)

Surgimab
All Listed Sponsors
collaborator

Dutch Cancer Society

OTHER

collaborator

Surgimab

INDUSTRY

lead

Leiden University Medical Center

OTHER